Boardroom Alpha Digest: Thurs, Feb 23

by | Feb 23, 2023

Executive News

  • Foot Locker (FL) named Robert Higginbotham as interim CFO following the departure of Andrew Page, who the company terminated “without cause under the terms of his employment arrangement and the Company’s benefit plans”
  • Gregory D. Smith, former CEO of Boeing, will assume the role of Chairman of American Airlines (AAL) following former AAL CEO Doug Parker’s retirement from the board.
  • Belden Inc. (BDC) named Ashish Chand as its new CEO taking over from Roel Vestjens who resigned

Activism

  • Dan Loeb and Third Point have positioned that they intend to launch a proxy fight at Bath and Body Works (BBWI), and plans to nominate a shareholder nominee to the company’s board

IPOs Upcoming

  • NYIX, INC. (NYX) is expected to price ~$9-10M IPO at $5 per share on 2/24
  • NAVA HEALTH MD, LLC (NAVA) is looking to price $8.1M at $6 per share on 2/28

SPACs

  • Insurers are said to receive a small win in the Social Capital Hedosophia Holdings III / Clover Health (CLOV) SPAC D&O Case
  • Decarbonization Plus Acquisition Corp. IV (DCRD) and Hammerhead Resources finally closed their business combination, and shares will trade as HHRS on Monday, 2/27
  • Warburg Pincus is shutting down their SPACs as both I-A and 1-B will liquidate

SPAC Calendar

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.